Absci Corp
ABSI
7.51
-0.65
-7.97%
Absci Corp
US · ABSI
#2817 by market cap
Listed 2021
7.51
-0.65
-7.97%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Absci Corp
Absci Corp. engages in drug discovery with generative design to create biologics for patients. Its platform combines AI models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. The firm has its own pipeline of AI designed therapeutics including ABS-201 and ABS-202. Absci Corp was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
- Founded
- 2011
- CEO
- Mr. Sean McClain
- Employees
- 140
- Headquarters
- Vancouver, Washington, United States of America
- Fiscal year end
- 12-31
- Website
- absci.com
Company profile
- Exchange
- US
- Symbol
- ABSI
- Market-cap rank
- #2817
- Listing date
- 2021-07-22
- Market cap
- 1.30B
- Float cap
- 1.24B
- Shares out
- 172.75M
- Float shares
- 164.74M
Sectors & themes
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
Absci Corp discussion 0 comments